PremiumThe FlyQuanterix downgraded to Market Perform from Outperform at Leerink Akoya Biosciences and Quanterix Amend Merger Agreement Quanterix, Akoya Biosciences announce amended merger agreement PremiumThe FlyAkoya Biosciences price target lowered to $1.65 from $2.40 at Piper Sandler Akoya Biosciences, Team SAMBAI announce selection of PhenoCycler-Fusion Tikvah intends to vote against Quanterix’s proposed merger with Akoya PremiumRatingsAkoya Biosciences: Hold Rating Amid Revenue Decline and Merger Uncertainties Quanterix price target lowered to $15 from $20 at Canaccord Akoya Biosciences reports Q4 EPS (17c), consensus (16c) 
